Literature DB >> 25698478

More risk factors, less ischemia, and the relevance of MPI testing.

Randall C Thompson1, Adel H Allam.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25698478     DOI： 10.1007/s12350-015-0072-0

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  4 in total

1.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2013-12-18       Impact factor: 29.690

2.  Temporal trends in the frequency of inducible myocardial ischemia during cardiac stress testing: 1991 to 2009.

Authors:  Alan Rozanski; Heidi Gransar; Sean W Hayes; James Min; John D Friedman; Louise E J Thomson; Daniel S Berman
Journal:  J Am Coll Cardiol       Date:  2013-03-12       Impact factor: 24.094

3.  Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.

Authors:  Sripal Bangalore; Sunil Kumar; Mario Fusaro; Nicholas Amoroso; Michael J Attubato; Frederick Feit; Deepak L Bhatt; James Slater
Journal:  Circulation       Date:  2012-05-14       Impact factor: 29.690

4.  Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.

Authors:  C Baigent; L Blackwell; J Emberson; L E Holland; C Reith; N Bhala; R Peto; E H Barnes; A Keech; J Simes; R Collins
Journal:  Lancet       Date:  2010-11-08       Impact factor: 79.321
  4 in total
  9 in total

1.  Assessment of left ventricular ejection fraction reserve in an era of decreasing frequency of myocardial ischemia during myocardial perfusion imaging.

Authors:  Sonia R Samtani; Gregory S Thomas
Journal:  J Nucl Cardiol       Date:  2017-04-26       Impact factor: 5.952

2.  The significance of post-stress decrease in left ventricular ejection fraction in patients undergoing regadenoson stress gated SPECT myocardial perfusion imaging.

Authors:  Javier Gomez; Yasmeen Golzar; Ibtihaj Fughhi; Adebayo Olusanya; Rami Doukky
Journal:  J Nucl Cardiol       Date:  2017-02-08       Impact factor: 5.952

Review 3.  Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging Guidelines: Instrumentation, Acquisition, Processing, and Interpretation.

Authors:  Sharmila Dorbala; Karthik Ananthasubramaniam; Ian S Armstrong; Panithaya Chareonthaitawee; E Gordon DePuey; Andrew J Einstein; Robert J Gropler; Thomas A Holly; John J Mahmarian; Mi-Ae Park; Donna M Polk; Raymond Russell; Piotr J Slomka; Randall C Thompson; R Glenn Wells
Journal:  J Nucl Cardiol       Date:  2018-10       Impact factor: 5.952

4.  Temporal trends in test utilization and prevalence of ischaemia with positron emission tomography myocardial perfusion imaging.

Authors:  Firas J Al Badarin; Paul S Chan; John A Spertus; Randall C Thompson; Krishna K Patel; Kevin F Kennedy; Timothy M Bateman
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2020-03-01       Impact factor: 6.875

5.  The mystery poor prognosticator! Pharmacologic stress MPI prevalence and predictors: Insights from the Middle East.

Authors:  Mohamed Mandour Ali; Adel H Allam
Journal:  J Nucl Cardiol       Date:  2018-01-16       Impact factor: 5.952

6.  Prevalence and predictors of automatically quantified myocardial ischemia within a multicenter international registry.

Authors:  Donghee Han; Alan Rozanski; Robert J H Miller; Tali Sharir; Andrew J Einstein; Mathews B Fish; Terrence D Ruddy; Philipp A Kaufmann; Albert J Sinusas; Edward J Miller; Timothy M Bateman; Sharmila Dorbala; Marcelo Di Carli; Joanna X Liang; Damini Dey; Daniel S Berman; Piotr J Slomka
Journal:  J Nucl Cardiol       Date:  2022-02-16       Impact factor: 3.872

7.  Multicenter evaluation of stress-first myocardial perfusion image triage by nuclear technologists and automated quantification.

Authors:  Waseem Chaudhry; Nasir Hussain; Alan W Ahlberg; Lori B Croft; Antonio B Fernandez; Mathew W Parker; Heather H Swales; Piotr J Slomka; Milena J Henzlova; W Lane Duvall
Journal:  J Nucl Cardiol       Date:  2015-11-13       Impact factor: 5.952

8.  The EXERRT trial: "EXErcise to Regadenoson in Recovery Trial": A phase 3b, open-label, parallel group, randomized, multicenter study to assess regadenoson administration following an inadequate exercise stress test as compared to regadenoson without exercise for myocardial perfusion imaging using a SPECT protocol.

Authors:  Gregory S Thomas; S James Cullom; Therese M Kitt; Kathleen M Feaheny; Karthikeyan Ananthasubramaniam; Robert J Gropler; Diwakar Jain; Randall C Thompson
Journal:  J Nucl Cardiol       Date:  2017-02-21       Impact factor: 5.952

9.  Changing Drivers of Mortality Among Patients Referred for Cardiac Stress Testing.

Authors:  Alan Rozanski; Heidi Gransar; Sean W Hayes; John D Friedman; Louise E J Thomson; Daniel S Berman
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2021-05-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.